These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7990127)
1. Isolation of a peptide antagonist to the thrombin receptor using phage display. Doorbar J; Winter G J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127 [TBL] [Abstract][Full Text] [Related]
2. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists. Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706 [TBL] [Abstract][Full Text] [Related]
3. Development of potent thrombin receptor antagonist peptides. Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546 [TBL] [Abstract][Full Text] [Related]
4. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643 [TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342 [TBL] [Abstract][Full Text] [Related]
6. ADP-dependence of platelet activation induced by a thrombin receptor agonist. Savi P; Dol F; Herbert JM Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide. Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273 [TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells. Reilly CF; Connolly TM; Feng DM; Nutt RF; Mayer EJ Biochem Biophys Res Commun; 1993 Feb; 190(3):1001-8. PubMed ID: 8382482 [TBL] [Abstract][Full Text] [Related]
9. In vitro effect of a thrombin inhibition peptide selected by phage display technology. Meiring MS; Litthauer D; Hársfalvi J; van Wyk V; Badenhorst PN; Kotzé HF Thromb Res; 2002 Sep; 107(6):365-71. PubMed ID: 12565725 [TBL] [Abstract][Full Text] [Related]
10. Issues in the development of thrombin receptor antagonists. Brass LF Thromb Haemost; 1995 Jul; 74(1):499-505. PubMed ID: 8578513 [TBL] [Abstract][Full Text] [Related]
11. Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approach. Suttnar J; Dyr JE; Dolecková L Thromb Haemost; 2000 Jan; 83(1):165-70. PubMed ID: 10669171 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin displayed on filamentous phage as a receptor-specific agonist. Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827 [TBL] [Abstract][Full Text] [Related]
14. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340 [TBL] [Abstract][Full Text] [Related]
15. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin. Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764 [TBL] [Abstract][Full Text] [Related]
16. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852 [TBL] [Abstract][Full Text] [Related]
17. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379 [TBL] [Abstract][Full Text] [Related]
18. Designing scaffolds of peptides for phage display libraries. Uchiyama F; Tanaka Y; Minari Y; Tokui N J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816 [TBL] [Abstract][Full Text] [Related]
19. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand. Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389 [TBL] [Abstract][Full Text] [Related]
20. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin. Greco NJ; Tandon NN; Jones GD; Kornhauser R; Jackson B; Yamamoto N; Tanoue K; Jamieson GA Biochemistry; 1996 Jan; 35(3):906-14. PubMed ID: 8547272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]